The goal was to compare children with hemiplegia with those with diplegia within Gross Motor Functional Classification System (GMFCS) levels using multiple validated outcome tools. Specifically, we proposed that children with hemiplegia would have better gait and gross motor function within levels while upper extremity function would be poorer. Data were collected on 422 ambulatory children with cerebral palsy: 261 with diplegia and 161 with hemiplegia, across seven centers. Those with hemiplegia in each level performed significantly and consistently better on gait or lower extremity function and poorer on upper extremity and school function than those with diplegia. In GMFCS Level II, the group with hemiplegia walked faster (p=0.017), scored 6.6 points higher on Dimension E of the Gross Motor Function Measure (p=0.017), 6.7 points lower on Upper Extremity subscale of the Pediatric Outcomes Data Collection Instrument, and 9.1 points lower on WeeFIM selfcare (p=0.002). Basing motor prognosis on GMFCS level alone may underestimate lower extremity skills of children with hemiplegia, and overestimate those of children with diplegia.
Cerebral palsy (CP) describes a group of disorders of the development of movement and posture, causing activity limitation, that are attributable to non-progressive disturbances that occurred in the developing fetal or infant brain (Bax et al. 2005) . This definition covers a wide range of clinical presentations and degrees of activity limitation, so efforts to classify individuals with CP into more homogeneous subgroups are justifiable and important for advancing research and clinical practice. Traditional schemes have differentiated children solely on the type of tone abnormality, such as spastic, dyskinetic, and ataxic, and distribution of limb involvement, such as hemiplegia, quadriplegia, and diplegia (Minear 1956, Delgado and Albright 2003) . The Gross Motor Functional Classification System (GMFCS) was developed as a method of differentiating children with the diagnosis of CP by their level of functional mobility (Palisano et al. 1997 ). The GMFCS is a simple, valid, and objective classification method that consists of five levels ranging from Level I, which includes children with minimal or no disability with respect to community mobility, to Level V, which includes children who are totally dependent on external assistance for mobility. Motor development curves by level have been determined for the purpose of more accurately predicting gross motor prognosis . The GMFCS has been rapidly accepted into clinical practice and research (Morris and Bartlett 2004) , and has been shown to be related directly to restrictions in activity and participation (Beckung and Hagberg 2002) .
Ambulatory children with CP, the primary focus of the Functional Assessment Research Group that conducted this study, typically fall into GMFCS Levels I, II, and III. The majority (70%) of children with bilateral spastic CP, and virtually all children with unilateral motor impairment, are eventually able to ambulate, although the onset of walking may be delayed and some level of difficulty may be experienced (Crothers and Paine 1959, Bleck 1987a ). The GMFCS does not, nor was it intended to, distinguish between unilateral and bilateral CP, and if this scheme was used solely for describing the current level of functional mobility, grouping in this manner would not be problematic. However, since the additional purposes of the GMFCS are to predict the rate of gross motor development and estimate the prognosis for future motor functioning using the gross motor curves, grouping children with notably different clinical presentations, and presumably different profiles of brain injury, may lead to inaccurate predictions of developmental rate and prognosis for both groups. This classification scale focuses primarily on lower limb gross motor function with little attention to the upper extremities, except as a means of activating a mobility device, or as an assist in maintaining or assuming upright postures. We were also interested in how these two clinical subgroups might differ across other areas, such as upper extremity abilities and cognitive and school functioning, as measured by several of the instruments used. Therefore, our specific objective was to determine whether children with unilateral lesions, commonly termed hemiplegia, and those with bilateral lesions but who are ambulatory, commonly termed diplegia, within the same GMFCS level have similar profiles across multiple outcomes instruments. We hypothesized that the two groups are likely to have divergent functional profiles such that the group with hemiplegia compared with the group with diplegia within the same GMFCS level would demonstrate significantly better gait and lower extremity function but worse upper extremity function. The rationale for presuming these differences between groups is based on the 'classic' clinical presentations of children with spastic diplegia versus those with hemiplegia. Children with hemiplegic CP tend to walk at an earlier age than those with diplegia (Bleck 1987a) . In general, the compensatory motor strategies for children with hemiplegia and a relatively, although not completely, intact lower extremity are better than those with bilateral involvement (Gage 1991) . Furthermore, the focus of treatment is mainly on the foot and ankle as well as the upper extremity for mild to moderately affected children with hemiplegia, whereas for those with diplegia, the knee and hip are more often likely to be impaired (Bleck 1987a, b, c; Abel and Damiano 2002) . These clinical differences are based on the differences in timing and etiology of the brain lesions, although neither of these groups is homogeneous (Uvebrant 1988 , Khaw et al. 1994 , Okumura et al. 1997 . Two out of three children with hemiplegia were born full term, and in that subset with hemiplegia, many have gray matter lesions. In contrast, children with diplegia are far more likely to have been born preterm and, when born at term, are more likely to have experienced intrauterine periventricular leukomalacia in the third trimester (Hagberg et al. 1996 , Krägeloh-Mann 2000 . A secondary purpose, assuming differences would be found, was to determine which tools and, more specifically, which functional characteristics best differentiate these groups. The ultimate goal is to develop functional profiles for each and to evaluate the validity of combining these groups in a functional classification scheme such as the GMFCS.
Method
Data reported here are a subset of those collected during the cross-sectional phase of a prospective 3-year multicenter study of patients from seven centers with the diagnosis of CP and GMFCS Level I, II, or III. The Functional Assessment Research Group consists of five Shriners Hospitals for Children and two other academic institutions. The main purpose of the larger cross-sectional study was to evaluate comprehensively and compare the Body Functions, Activity & Participation of ambulatory children with CP, as described by the International Classification of Functioning, Disability and Health (ICF) published by the World Health Organization (2001), and Quality of Life profiles of children within each of these three GMFCS levels (Oeffinger et al. 2004) . In this study we subdivided further the sample by type of CP to evaluate potential differences between them, and to determine which instruments best discriminated these groups. Ancillary analyses included evaluation of ceiling effects across instruments and groups, and evaluation of possible differences between children with left and right hemiplegia.
PARTICIPANTS
Participants were recruited from patients seen in the motion laboratory or the outpatient clinic of each facility. All required Institutional Review Board and Health Insurance Portability and Accountability Act approvals and appropriate consent and assent forms from participants were obtained. Children with the diagnosis of CP, classified as GMFCS Levels I, II, and III, between the ages of 4 and 18 who could ambulate independently with or without assistive devices a minimum of 15 feet without resting were identified for inclusion in this study. Patients were excluded if they had previously had a selective dorsal rhizotomy or other surgery within the last year, botulinum toxin A injections in the past 6 months, or a currently implanted and operating Baclofen pump.
In all, 562 children participated in the cross-sectional phase of this study and were assigned a GMFCS level (Palisano et al. 1997) as the main grouping factor for analyses. Children were further subgrouped within GMFCS levels as hemiplegic or diplegic. Since only one child with hemiplegia was in GMFCS Level III, we could not compare children in that level, thus resulting in a total of 422 children whose data were utilized for this study. Table I provides the demographics for this sample.
OUTCOME TOOLS
The following tools were administered: (a) 3-D gait analysis temporal-spatial data; (b) the Gross Motor Function Measure (GMFM) Dimension D (Standing) and E (Walking, Running, Jumping) from which a GMAE (Gross Motor Ability Estimator) score was also computed; and (c) Energy Cost (O 2 cost) of walking in four centers that had this capacity. was additionally assessed here.
PROCEDURES
All study coordinators were trained to ensure standardized data collection and administration of all instruments. A custom data collection and management software package was developed in which all data were entered directly. Parent and child tools were completed using direct entry via a touchscreen monitor. To reduce the possible effect of fatigue on participant responses, the order of the instrument completion was randomized using a random number generator embedded in the software.
DATA ANALYSES
De-identified data from each site were sent monthly to the coordinating center (Lexington, KT, USA) and compiled for analyses. To analyze the differences between children with diplegia and hemiplegia within levels, a two-way analysis of variance (ANOVA) procedure was used (p<0.05). Readers should be aware that the decision was made a priori not to correct for multiple comparisons. Our rationale for this was that even though the frequency of Type I errors may be higher, our purpose was to examine patterns of differences across GMFCS levels in the larger study and also between hemiplegia and diplegia in this study. The more stringent p value for determining significance would have masked clinically significant differences, thus increasing the frequency of Type II errors which we felt was more problematic in this type of study. Between-participant factors were GMFCS Levels (I or II) and group (hemiplegia or diplegia). Dependent measures were all assessment scores. Stepwise logistic regression procedures were used to determine which instruments best discriminated the two diagnostic categories, controlling for GMFCS level, and the model was tested to determine how well it was able to predict the two groups. Other analyses included the use of Fisher's exact test and logistic regression to compare the rate of occurrence of ceiling effects across diagnoses within levels. Two-way ANOVA procedures were used to compare scores for children with right versus left hemiplegia.
Results
The first hypothesis concerned the differences between children with hemiplegia and diplegia within GMFCS levels. The mean values and 95% confidence intervals (CI) for each tool are listed in Table II , with significant differences in bold. Table  III summarizes the significant results by indicating on which tools the children with hemiplegia were better and on which they were worse by GMFCS level. Children with hemiplegia were consistently better on nearly all tools related to gait or lower extremity function with none being worse, and consistently poorer on tools related to upper extremity and school function.
Similar results were found when the analysis was done with group as the sole between-participants factor while controlling for GMFCS level. In that case, those with diplegia had higher PODCI Parent Upper Extremity Function subscale scores, higher WeeFIM self-care and cognition scores, and higher PedsQL Child School score. Children with hemiplegia had significantly higher GMFM D & E and GMAE scores, higher FAQ1, faster veloc- ity and longer stride lengths, and a lower (better) O 2 cost. Significant interaction effects (Group x GMFCS level) were seen in the PedsQL Parent School scores and the WeeFIM cognition scores, with both decreasing to a greater extent with GMFCS level in children with hemiplegia. An opposition pattern was found for the GMAE which increased to a greater extent in the lower GMFCS level in children with hemiplegia. An interaction was also seen with cadence, but in that case, the children with hemiplegia were able to maintain cadence in GMFCS Level II, whereas this value was slightly lower in those with diplegia.
The second hypothesis addressed which tools best discriminated between groups when controlling for GMFCS scores. The data set was randomly split into a training set consisting of two out of three of the study participants (n=281) and a validation set made up of the remaining one-third of participants (n=141). A logistic regression model using a stepwise selection process identified the following tools in this order: GMFM D, PODCI (P) Upper Extremity Function, FAQ3 (A [answer] 17), FAQ3 (A12), FAQ3 (A2), PODCI (P) Transfers & Mobility, FAQ2 (A5). The FAQ consists of three questions with FAQ2 and FAQ3 having 7 and 22 answers respectively, each of which lists a specific limitation in FAQ2 or skill in FAQ3 that can stand alone as a single item. When the model was tested using the validation set, it did an excellent job of correctly identifying children with diplegia (85% of the time), but not as well identifying children with hemiplegia (46% of the time).
Several tools used to assess function in CP have been observed to have ceiling and/or floor effects for children at the extremes of the functional levels. If these occur frequently, they could affect the results, particularly if they occur more in one diagnostic category than another, and more importantly, would limit the ability of these tools to discriminate and to evaluate children over time or as a result of an intervention. The frequency of ceiling effects was computed for each tool. The question addressed here was whether the percentage of ceiling effects differed across groups within GMFCS levels and with the levels collapsed. Ceiling effects were shown to be a function of the tool, GMFCS level, and subtype. Ceiling effects were generally, but not entirely, higher in GMFCS Level I (Table IV) . They were not consistently higher in either subtype, but generally reflected the different strengths in each of the groups, e.g. the children with hemiplegia had a significantly higher percentage of ceiling effects in the PODCI Transfers & Basic Mobility subscale and the WeeFIM mobility domain which reflect their consistently higher scores on lower extremity function tests. In contrast, the children with diplegia had a higher percentage of ceiling effects on the WeeFIM self-care domain which reflects their relatively better upper extremity function. Ceiling effects may also have made differences between groups less apparent.
The last comparison was between children with left versus right hemiplegia to determine if any of the differences could be explained by laterality of the brain lesion (Table V) . Children with right versus left hemiplegia were generally very similar with only a few small, but significant, differences found in the PedsQL Child School Score, WeeFIM self-care, and WeeFIM mobility, all interestingly favoring those with right hemiplegia.
Discussion
This study provides objective evidence of the distinct differences between children with diplegia and hemiplegia in various aspects of motor functioning, activity, participation, and quality of life, many of which are hardly surprising to those who are involved in the care of these children. What is perhaps more surprising is that children within the same mobility classification level show an evident and consistent pattern of differences, such that those with hemiplegia clearly show better gait and lower extremity mobility scores compared with those with diplegia. Systematic differences in the percentage of ceiling effects across groups further suggests that the differences between groups on these and the other significant aspects noted may be even greater than measured. This functional difference can be best explained by the presence of one higher functioning, if not completely normal, lower limb in hemiplegia (Wiley and Damiano 1998) . The clinically relevant consequences of these differences are that the motor prognoses for each of these groups based on the GMFCS classification alone and the associated motor development curves may be either underestimated in the case of hemiplegia or overestimated in the case of diplegia. An argument could be made that these groups should be classified separately and that separate developmental trajectories be proposed to improve prognostic precision with respect to predicting future mobility. A counter argument could be made that that classification of CP should instead be multiaxial with GMFCS as one axis and type of CP as another (Bax et al. 2005) . In that case, it does not matter that the GMFCS and the topographical description of CP do not map onto one another well as has been shown to be the case by Gorter et al. (2004) , and one would need to accept that these two ways of differentiating children with CP are giving us separate pieces of information that would need to be integrated by the clinician. The fact that children with hemiplegia tended to have poorer upper extremity function as reflected by a tendency to have lower self-care skills, also argues for a separate classification of and tools for assessing upper extremity function, several of which have recently been proposed (Eliasson et al. 2006) . One of the limitations in making this topographical distinction is that differentiation of hemiplegia and diplegia is not necessarily straightforward, and some blurring between categories is likely to exist such that some children diagnosed with hemiplegia may actually have an asymmetric diplegia (Krägeloh-Mann et al. 1995) . Timing and type of brain injuries also overlap considerably across these two categories, each of which will have an influence on the developmental outcome. One of the main reasons for advocating a more multidimensional approach to classification rather than an unidimensional one is that this could ultimately lead to greater diagnostic precision and predictability of treatment outcomes (Bax et al. 2005) . In this proposed classification, unilateral and bilateral lesions would be differentiated, preferably by imaging when available, and both upper and lower extremity functional levels would be considered using valid and reliable tools. Accompanying impairments, timing, and type of injury and etiologic cause if known would all be factored into the differentiation of patient clusters. Clearly, more work is needed so that these schemes can be refined and validated.
It is important to note that the percentage of those studied with hemiplegia in GMFCS Level II was higher than the population-based estimate presented by Gorter et al. (2004) which overwhelmingly (88% of cases) placed children with hemiplegia in GMFCS Level I. This difference may be due to the fact that this sample was formed on the basis of those sent to motion analysis laboratories for clinical studies, so a bias towards children with more extensive lower limb involvement is not unexpected. Therefore, the sample of children studied here does not represent a random sampling of patients receiving care at any particular center as was the case in Gorter et al.'s study. It is also possible that there were systematic differences in how the GMFCS levels were determined across studies.
Differences between groups found here, while fairly consistent in their pattern, were not large in magnitude for the most part. These were probably attenuated by the lack of diagnostic precision as noted above and by the occurrence of ceiling effects, but one must always be concerned with the clinical significance of differences, especially when evaluating data from large samples where statistical significance is easier to achieve and can be found even when differences are very small. The estimated minimal clinically significant difference has been published for the total GMFM Total Score, but to the best of our knowledge, this information is not available for the other measures used here and, therefore, remains to be determined. Had Bonferroni corrections been applied here, the only differences that would have still reached significance (p<0.013) were a lower O 2 cost measured and predicted for those with hemiplegia in GMFCS Level I.
The main message here should perhaps be that one should not make assumptions about one aspect of function based on another (Kennes et al. 2002) , and that comprehensive assessment of strengths and weaknesses across multiple aspects of functioning is warranted if one wants to optimize participation and quality of life for each individual. Furthermore, the response of a group of patients to treatments is likely to vary more as heterogeneity increases. Based on that assumption and given the results here, it is our further recommendation that these groups not be combined in clinical outcome studies. 
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